Seroatlas · Human Serome Atlas

CD47

Leukocyte surface antigen CD47

Also known as: CD47_HUMAN, IAP, MER6, OA3

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q08722
Gene
CD47
Ensembl
ENSG00000196776
Chromosome
3
Canonical length
323 aa
Protein class
CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters
Subcellular location
Vesicles,Plasma membrane

OverviewNCBI Gene

This gene encodes a membrane protein, which is involved in the increase in intracellular calcium concentration that occurs upon cell adhesion to extracellular matrix. The encoded protein is also a receptor for the C-terminal cell binding domain of thrombospondin, and it may play a role in membrane transport and signal transduction. This gene has broad tissue distribution, and is reduced in expression on Rh erythrocytes. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2010]

Canonical amino-acid sequenceUniProt

323 residues, UniProt reviewed canonical sequence.

>Q08722|CD47
     1  MWPLVAALLL GSACCGSAQL LFNKTKSVEF TFCNDTVVIP CFVTNMEAQN TTEVYVKWKF
    61  KGRDIYTFDG ALNKSTVPTD FSSAKIEVSQ LLKGDASLKM DKSDAVSHTG NYTCEVTELT
   121  REGETIIELK YRVVSWFSPN ENILIVIFPI FAILLFWGQF GIKTLKYRSG GMDEKTIALL
   181  VAGLVITVIV IVGAILFVPG EYSLKNATGL GLIVTSTGIL ILLHYYVFST AIGLTSFVIA
   241  ILVIQVIAYI LAVVGLSLCI AACIPMHGPL LISGLSILAL AQLLGLVYMK FVASNQKTIQ
   301  PPRKAVEEPL NAFKESKGMM NDE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CD47 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
5
Mean surface accessibility (rSASA)
0.33
Highest tissue expression
264 nTPM

Expression across tissuesHPA

Tissue

  • retina: 264 nTPM
  • bone marrow: 219 nTPM
  • tonsil: 151 nTPM
  • lung: 146 nTPM
  • lymph node: 129 nTPM
  • prostate: 115 nTPM

Single-cell type

  • alveolar cells type 1: 618 nCPM
  • gastric progenitor cells: 440 nCPM
  • thymocytes: 435 nCPM
  • platelets: 402 nCPM
  • parietal cells: 373 nCPM
  • esophageal suprabasal cells: 361 nCPM

Immune cell

  • non-classical monocyte: 341 nTPM
  • T-reg: 336 nTPM
  • total PBMC: 298 nTPM
  • intermediate monocyte: 245 nTPM
  • eosinophil: 234 nTPM
  • NK-cell: 234 nTPM

Brain region

  • white matter: 157 nTPM
  • cerebellum: 136 nTPM
  • medulla oblongata: 117 nTPM
  • cerebral cortex: 112 nTPM
  • thalamus: 110 nTPM
  • spinal cord: 109 nTPM

ReferencesPubMed · IEDB

Publications for CD47 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.37
gnomAD pLI
0.92
gnomAD missense Z
1.43
DepMap mean gene effect
0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CD47 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CD47 as an antibody target. Whether an autoantibody or antibody against CD47 could matter depends on whether native CD47 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CD47 is annotated at the cell surface, where native CD47 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label CD47 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CD47. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...